To update 2 National High Blood Pressure Education Program working group reports on hypertension and chronic renal failure and renovascular hypertension, a working group was appointed by the director of the National Heart, Lung, and Blood institute.
Literature was searched through MEDLINE and the National Heart, Lung, and Blood Institute information center library.
Scientific evidence was given precedence over clinical anecdotal experience.
The working group members produced initial draft documents that were circulated to additional experts on hypertension and renal disease.
This reiterative process occurred for 18 draft documents.
The final report was sent to the representatives of the 44 organizations on the Coordinating Committee for vote and unanimously approved September 1,1995.
The report recommended treatment of hypertension to the goal of 130/85 mm Hg with whatever therapy is necessary to prevent the development of hypertensive nephrosclerosis or the progression of established renal disease of diverse causes.
It seems reasonable to recommend angiotensin-converting enzyme inhibitors as initial therapy for patients with diabetes and microalbuminuria or overt diabetic nephropathy with and without hypertension.
Renovascular disease has emerged as a major cause of end-stage renal disease, especially in the elderly. (...)
Mots-clés Pascal : Hypertension artérielle, Artère rénale pathologie, Insuffisance rénale, Chronique, Recommandation, Contrôle, Pression sanguine, Chimiothérapie, Association morbide, Etude critique, Homme, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Artère pathologie, Appareil urinaire pathologie, Rein pathologie
Mots-clés Pascal anglais : Hypertension, Renal artery disease, Renal failure, Chronic, Recommendation, Check, Blood pressure, Chemotherapy, Concomitant disease, Critical study, Human, Cardiovascular disease, Vascular disease, Arterial disease, Urinary system disease, Renal disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0450070
Code Inist : 002B12B05B. Création : 10/04/1997.